ClinicalTrials.Veeva

Menu

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

B

Boryung

Status and phase

Completed
Phase 1

Conditions

Hypertension
Hyperlipidemia

Treatments

Drug: Fimasartan/Amlodipine/Rosuvastatin
Drug: Fimasartan/Amlodipine
Drug: Rosuvastatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT02569814
BR-FARC-CT-102

Details and patient eligibility

About

A Open-label, Randomized, Single-dose, 2x2 Crossover Study to Compare the Pharmacokinetics and Safety between a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin versus Co-administration of a Fixed Dose Combination of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects.

Enrollment

100 patients

Sex

Male

Ages

19 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • a Healthy male subject, aged 19- 50 years

Exclusion criteria

  • History of clinically significant hypersensitivity to study drug, any other drug
  • Hypotension or hypertension
  • Active liver disease
  • History of gastrointestinal disease
  • History of excessive alcohol abuse
  • Participation in any other study within 3 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Group 1
Other group
Description:
Subjects of Group 1 take Fimasartan/Amlodipine Combination Tablet and Rosuvastatin Individual Tablets at 1st day as period I. And then, after wash out for 2 weeks, as period II, subjects of Group 1 take a Fimasartan/Amlodipine/Rosuvastatin Combination Tablet at 15th day.
Treatment:
Drug: Rosuvastatin
Drug: Fimasartan/Amlodipine/Rosuvastatin
Drug: Fimasartan/Amlodipine
Group 2
Other group
Description:
Subjects of Group 2 take a Fimasartan/Amlodipine/Rosuvastatin Combination Tablet at 1st day as period I. And then, after wash out for 2 weeks, as period II, subjects of Group 2 take Fimasartan/Amlodipine Combination Tablet and Rosuvastatin Individual Tablets at 15th day.
Treatment:
Drug: Rosuvastatin
Drug: Fimasartan/Amlodipine/Rosuvastatin
Drug: Fimasartan/Amlodipine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems